Cargando…

CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1

Tumour metastasis, the spread of cancer cells from the original tumour site followed by growth of secondary tumours at distant organs, is the primary cause of cancer-related deaths and remains poorly understood. Here we demonstrate that inhibition of CDK4/6 blocks breast tumour metastasis in the tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tongzheng, Yu, Jia, Deng, Min, Yin, Yujiao, Zhang, Haoxing, Luo, Kuntian, Qin, Bo, Li, Yunhui, Wu, Chenming, Ren, Tao, Han, Yang, Yin, Peng, Kim, JungJin, Lee, SeungBaek, Lin, Jing, Zhang, Lizhi, Zhang, Jun, Nowsheen, Somaira, Wang, Liewei, Boughey, Judy, Goetz, Matthew P., Yuan, Jian, Lou, Zhenkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228031/
https://www.ncbi.nlm.nih.gov/pubmed/28067227
http://dx.doi.org/10.1038/ncomms13923
Descripción
Sumario:Tumour metastasis, the spread of cancer cells from the original tumour site followed by growth of secondary tumours at distant organs, is the primary cause of cancer-related deaths and remains poorly understood. Here we demonstrate that inhibition of CDK4/6 blocks breast tumour metastasis in the triple-negative breast cancer model, without affecting tumour growth. Mechanistically, we identify a deubiquitinase, DUB3, as a target of CDK4/6; CDK4/6-mediated activation of DUB3 is essential to deubiquitinate and stabilize SNAIL1, a key factor promoting epithelial–mesenchymal transition and breast cancer metastasis. Overall, our study establishes the CDK4/6–DUB3 axis as an important regulatory mechanism of breast cancer metastasis and provides a rationale for potential therapeutic interventions in the treatment of breast cancer metastasis.